Watson Boosts Women's Health Holdings In $305M Uteron Deal
Watson Pharmaceuticals Inc. has acquired Uteron Pharma SA in a deal valued at $305 million with the strategic goal of expanding the Parsippany, N.J.-based company's women's health products, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article